Wearables Manufacture
CTECH's manufacturing capability for its wearable device lines — ECCT garments and ECBS units — from engineering and component sourcing through assembly, quality testing, and distribution.
Manufacturing the wearable devices behind CTECH's therapies.
Wearables Manufacture is CTECH Laboratories Edwar Technology's production capability for its body-conforming device lines — the ECCT electrode garments (helmet, blanket, and pants forms) used in cancer therapy, and the ECBS units used for cellular stimulation and conditioning.
The facility covers the full path from device design to a finished, fitted unit: engineering and revision of garment electronics, sourcing of critical components, assembly, functional and safety testing, and packaging for clinical or distribution use.
In January 2026, Revotera Medical Technologies carried out a combined ISO 13485 quality management system audit and critical supplier audit across CTECH's manufacturing lines, assessing both ECCT and ECVT-related production in parallel as part of a broader effort to align manufacturing quality with the requirements of the global market.
From design to a fitted, tested device.
Two wearable device lines.
Manufactured for CTECH's own clinical services and for partner deployment.
ECCT Helmet
Head-worn electrode garment for intracranial and brain tumour applications, produced for use at the Cancer Therapy Lab and by clinical partners.
ECCT Blanket & Pants
Whole-body and localized electrode garments for metastatic, prostate, and other site-specific applications, fitted to individual patients.
ECBS Units
Wearable devices delivering electrical stimulation for cellular recovery and conditioning, manufactured for sport technology and cellular health applications.
Audited for global market readiness.
On January 5, 2026, Revotera Medical Technologies conducted an integrated audit of CTECH's manufacturing facility, running an ISO 13485 quality management system audit and a critical supplier audit simultaneously across CTECH's ECCT and ECVT lines.
The audit forms part of CTECH's broader effort, alongside Revotera Medical Technologies, to align its manufacturing standards and production quality with the requirements of the global market.
- ISO 13485 quality management system audit completed, January 2026
- Critical supplier audit run in parallel across ECCT and ECVT lines
- Focus on manufacturing readiness ahead of international market entry
ECCT
The ECCT device — specifications, mechanism, applications by cancer type, and the history of how the therapy was developed.
Cancer Therapy Lab
Where these garments reach patients — clinical protocol, intake, and monitoring through ECVT imaging.
Enquire about wearable device production.
For clinical partners and distributors — our team can discuss device specifications, production capacity, and quality documentation.